Mark J. Sculpher
Impact in
- Economics and Econometrics top 0.02%
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare Policy and Management
- Pharmaceutical Economics and Policy
- Economic and Environmental Valuation
- General Health Professions top 0.1%
- Healthcare cost, quality, practices
- Global Health Care Issues
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 161
- Healthcare Policy and Management 49
- Pharmaceutical Economics and Policy 27
- Economic and Environmental Valuation 11
-
- Healthcare cost, quality, practices 61
- Global Health Care Issues 14
- Co-authors
- Karl Philip Claxton (72 shared papers)Andrew H. Briggs (30 shared papers)Elisabeth A. L. Fenwick (13 shared papers)Andrea Manca (29 shared papers)Martin J Buxton (22 shared papers)Neil Hawkins (19 shared papers)Michael Drummond (8 shared papers)Michael Drummond (7 shared papers)
- Journals
- Health Technology Assessment (49 papers)PharmacoEconomics (35 papers)Value in Health (31 papers)Health Economics (22 papers)Medical Decision Making (18 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Mark J. Sculpher
390 papers receiving 30.6k citations
Mark J. Sculpher's Hit Papers
Peers
Comparison fields: 5 of 209
- Economics and Econometrics 7.8k
- General Health Professions 3.5k
- Obstetrics and Gynecology 773
- Anesthesiology and Pain Medicine 565
- Cardiology and Cardiovascular Medicine 2.1k
Countries citing papers authored by Mark J. Sculpher
This map shows the geographic impact of Mark J. Sculpher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Sculpher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Sculpher more than expected).
Fields of papers citing papers by Mark J. Sculpher
This network shows the impact of papers produced by Mark J. Sculpher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Sculpher. The network helps show where Mark J. Sculpher may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark J. Sculpher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 401 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Decision Modelling For Health Economic Evaluation Hit paper breakdown → | 2006 | 2550 |
| 2 | Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Hit paper breakdown → | 2016 | 2468 |
| 3 | Primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses. Hit paper breakdown → | 1998 | 915 |
| 4 | Representing uncertainty: the role of cost‐effectiveness acceptability curves Hit paper breakdown → | 2001 | 908 |
| 5 | Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utility Hit paper breakdown → | 2004 | 820 |
| 6 | An Introduction to Markov Modelling for Economic Evaluation Hit paper breakdown → | 1998 | 743 |
| 7 | Model Parameter Estimation and Uncertainty Analysis Hit paper breakdown → | 2012 | 689 |
| 8 | Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research Hit paper breakdown → | 2016 | 661 |
| 9 | Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold Hit paper breakdown → | 2015 | 608 |
| 10 | Review of guidelines for good practice in decision-analytic modelling in health technology assessment Hit paper breakdown → | 2004 | 567 |
| 11 | Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 Hit paper breakdown → | 2012 | 543 |
| 12 | 2017 | 453 | |
| 13 | Transferability of Economic Evaluations Across Jurisdictions: ISPOR Good Research Practices Task Force Report Hit paper breakdown → | 2009 | 423 |
| 14 | 1994 | 421 | |
| 15 | Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment Hit paper breakdown → | 2006 | 416 |
| 16 | The Lancet Commission on prostate cancer: planning for the surge in cases Hit paper breakdown → | 2024 | 385 |
| 17 | 2002 | 363 | |
| 18 | 2006 | 357 | |
| 19 | 2004 | 356 | |
| 20 | 2005 | 356 |
About Mark J. Sculpher
Mark J. Sculpher is a scholar working on Economics and Econometrics, General Health Professions, Cardiology and Cardiovascular Medicine, Infectious Diseases and Obstetrics and Gynecology, having authored 401 papers that have together received 31.8k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (161 papers), Healthcare cost, quality, practices (61 papers), Healthcare Policy and Management (49 papers), Pharmaceutical Economics and Policy (27 papers), HIV/AIDS Research and Interventions (18 papers), Global Health Care Issues (14 papers), Economic and Environmental Valuation (11 papers) and Cardiac Imaging and Diagnostics (10 papers). The work is most often cited by research in Economics and Econometrics (7.8k citations), General Health Professions (3.5k citations), Obstetrics and Gynecology (773 citations), Anesthesiology and Pain Medicine (565 citations) and Cardiology and Cardiovascular Medicine (2.1k citations). Mark J. Sculpher has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Karl Philip Claxton, Andrew H. Briggs, Elisabeth A. L. Fenwick, Andrea Manca, Martin J Buxton, Neil Hawkins, Michael Drummond, Michael Drummond, Su Golder and Stephen Palmer. Their work appears in journals such as Health Technology Assessment, PharmacoEconomics, Value in Health, Health Economics and Medical Decision Making.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.